Phosphoenix

Phosphoenix is developing a novel neuroprosthetic approach to restore functional vision in people with profound blindness by directly stimulating the brain’s visual pathway

Healthcare & Digital Health

Sector

Seed

Stage

Medical device development

Model

01Company Overview

Phosphoenix is developing a novel neuroprosthetic approach to restore functional vision in people with profound blindness by directly stimulating the brain’s visual pathway. The company focuses on high-density, ultra-flexible neural interfaces designed for precise stimulation of the brain.

02Backed By2 investors

BVBioGeneration Ventures→TMTTT Medtech Fund→

Is this your company? Claim your profile

Startup Intelligence by F4F4 Research Engine

Companies with the same backers

1 company

XS InnovationsBiotech & Life Sciences

BioGeneration Ventures, TTT Medtech Fund

Find the investors for your round→

04Recent Activity

FROM TTT Medtech Fund

Participated in Phosphoenix's EUR 1.3M financing round via TTT Medtech Fund, alongside FIRST Fund (BioGeneration Ventures), Innovatiefonds Noord-Holland and ROM InWest, to advance a visual neuroprosthetic toward first-in-human study.